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Abstract
There is an ongoing increase in the availability of foods fortified with micronutrients and dietary supplements.
This may result in differing intakes of micronutrients within the population and perhaps larger differences in
intakes. Insight into population micronutrient intakes and evaluation of too low or too high intakes is
required to see whether there are potential problems regarding inadequacy or excessive intakes. Too low
population intakes are evaluated against an estimated average requirement; potential too high population
intakes are evaluated against a tolerable upper intake level (UL). Additional health effects, seriousness, and
incidence of these health effects are not considered but these can be taken into account in a benefit-risk
assessment. Furthermore, authorities would like to regulate food fortification and supplementation in such a
way that most of the population is not at risk of potentially high intakes. Several models are available for
estimating maximum levels of micronutrients for food fortification and dietary supplements. Policy makers
and risk managers need to decide how to divide the ‘free space’ between food fortification and/or dietary
supplements, while protecting populations from adverse health effects.
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A
dequate vitamin and mineral intakes are essential
for the maintenance of health and disease pre-
vention. Dietary intake is the most important
source for micronutrients. A well-known exception to this
is vitamin D with relatively small amounts available
through dietary sources and status being mainly reliant
on exposure to ultra-violet light. The role of optimal
nutrition in the prevention of chronic disease is well esta-
blished and, therefore, diet is recognised as a vital
component of disease prevention strategies.
Socio-economic advancements have resulted in rapid
changes to diet and lifestyle over the past few decades.
Although life expectancy has steadily increased, this has
coincided with a dramatic increase in the prevalence of
chronic disease. Both too low and too high intakes are
associated with adverse health effects. An adverse health
effect has been defined as any impairment of a physio-
logically important function (1) and as any change in
morphology, physiology, growth, development or life
span of an organism that results in impairment of
functional capacity or impairment of capacity to com-
pensate for additional stress or increase in susceptibility
to the harmful effects of other environmental influences
(2, 3). The prevention of both too low and too high
intakes is therefore imperative for the maintenance of
health. Current strategies for the modification of popula-
tion diets that are found to have too low or too high
intakes include nutrition education, food fortification,
and/or the use of dietary supplements. Careful considera-
tion must be given to any strategies aimed at dietary
change ensuring the needs are met for particular sub-
groups that may have high prevalence of suboptimal or
excessive intakes. The need for regulation of specific
nutrients depends on the severity of the adverse health
effects, taking into consideration all population sub-
groups. A benefit-risk assessment may be necessary to
help predict the impact of varying levels of nutrient
intakes on health maintenance, chronic disease preven-
tion, and safe intakes. In this paper we will give an
overview of the state of the art on estimation of the
prevalence of too low and too high population in-
takes including population reference intakes (PRI) and
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tolerable upper intake levels (UL), benefit-risk assess-
ment, and the estimation of maximum safe fortification
and supplementation levels.
Population reference intakes and evaluation of too
low intakes
The ideal method for the estimation of suboptimal
micronutrient intakes is to compare individual habitual
micronutrient intake with individual micronutrient re-
quirement. This would allow the demonstration of the
proportion of the population with nutrient intakes that
are too low. Unfortunately, this method of examination is
not possible as individual requirements are unknown (4).
The evaluation of micronutrient intakes at a popula-
tion level has resulted in several (inter)national expert
committees setting recommendations for the intake of
each micronutrient for their population. Different types
of PRI are used, for example, Estimated Average
Requirement (EAR), Recommended Daily Allowance
(RDA), and Adequate Intake (AI). Although physio-
logical micronutrient requirements are obviously very
similar across different countries, the difference in opin-
ions between expert committees has resulted in wide
variation in nutrient recommendations within Europe
and beyond (57). This issue highlighted the need for
consensus of European micronutrient recommendations.
The EURRECA project has proposed a general frame-
work to align the process of establishing micronutrient
requirements in Europe (8).
Nutritional reference intakes are based on the concept
of nutrient requirement. For a micronutrient, the require-
ment may be defined as the lowest level of habitual intake
that will maintain a defined level of nutriture in an
individual (9). The requirement can be deemed adequate
when it prevents the signs of deficiency diseases or when
it reduces the risk of chronic diseases (9). Requirements
vary between individuals. As such, within a population
there is a distribution of requirements for every micro-
nutrient for any given definition of adequacy (e.g. prevent
classic nutrient deficiency, reduce risk of chronic diseases,
or a change in a biochemical parameter). The PRI are
generally set for different life stages and gender groups
within a population. The EAR (Fig. 1) is the daily intake
value that is estimated to meet the requirement in 50% of
the individuals in a life stage or gender group (9).
Requirements are usually assumed to be distributed
normally (10) and the coefficient of variation (SD/
mean) of the requirement is generally assumed to be
10% (9) to 15% (1012). Once the EAR is set and the
requirement distribution is described, the RDA is located
at the point on the distribution at which intake is
adequate for 97%98% of the population group. For
most micronutrients, assuming a normal distribution
of requirements, the RDA can be calculated as the
EAR2 SD of the requirement or assuming a CV of
10% (or 15%): RDA1.2 (or 1.3)EAR. As the EAR
is set for different life stages and gender groups, so is
the RDA.
A frequently encountered misconception in evaluating
the prevalence of inadequate intakes is comparing
habitual intakes with RDA values. The RDA values are
already more than adequate for almost all in the
population. Therefore, the proportion of the population
with intakes below the RDA is not equal to the
proportion with inadequate intakes (4). The proportion
of the population for which intake is inadequate may
correctly be estimated using the EAR cut-point method
(13, 14). The proportion of the population with intakes
below EAR has been shown to be a realistic estimate of
the prevalence of suboptimal dietary intakes in a
population (14). It is important to notice that there are
some assumptions underlying the EAR cut-point
method. When these assumptions are not met the EAR
cut-point method will give a biased estimate of the
prevalence of inadequate intakes (14, 15).
An alternative to assess the prevalence of inadequate
intake is the probability method (14, 16). In this method,
given a distribution of requirements a risk curve is
computed. This risk curve associates certain intake levels
with the risk of inadequate intake. The prevalence of
inadequate intakes is then estimated by combining the
habitual intake distribution with the risk curve. Again,
several assumptions are made in this method and it is
required to have the distribution of requirements.
Assumptions on, for instance, the shape of the require-
ment distribution will highly influence the outcome of the
prevalence estimate. A drawback is that the EAR values
(and other PRIs) are currently set in age-steps rather than
continuously over ages. Therefore evaluation of dietary
intakes is also in age-steps, rather than continuously over
ages. In order to overcome age-steps, recently a contin-
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Fig. 1. A normal frequency of distribution of individual
requirements for a nutrient. Abbreviations: EAR  estimated
average requirements (mean/median requirement of the
population); RDA  recommended daily allowance (mean
requirement plus 2 SD  the intake that meets the needs of
97%98% of healthy individuals in a population).
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uous methodology was developed, which more readily
reflects continuous requirements over life (17); however,
this method does need PRIs set continuously over ages.
When an EAR cannot be estimated, a less precise
reference intake is often estimated e.g. the AI (9). This
measure cannot be used to evaluate inadequate intakes in
a population quantitatively because the relationship of
such reference values to the requirement for the nutrient
is unknown. Only a qualitative statement can be made; if
the median habitual intake is at or above the AI, the
prevalence of too low intakes can be stated to be ‘low’,
whereas no statement can be made if the median habitual
intake is below the AI (15).
Tolerable upper intake levels and evaluation of
high intakes
Besides inadequate intakes due to too low micronutrient
intakes, excessive intakes may also result in adverse health
effects. In order to be able to evaluate and manage
potential excessive micronutrient intake, several (inter)na-
tional committees, for example the European Food Safety
Authority (EFSA) and Institute of Medicine (IOM), have
set tolerable upper intake levels (ULs) (1, 18). The UL is
the maximum level of total chronic daily intake of a
nutrient (from all sources, including foods, water, nutrient
supplements, and medicines) judged to be unlikely to
pose a risk of adverse health effects to almost all
individuals in the general population (18). ‘Tolerable’
implies a level of intake that can be tolerated physiolo-
gically by humans. Like PRI values, ULs may be derived
for various life stage groups in the population (e.g. adults,
pregnant and lactating women, infants, and children).
The UL is not a recommended level of intake but is an
estimate of the highest level of habitual intake that carries
no appreciable risk of adverse health effects. It is
important to realise that the UL is a different type of
measure than an EAR. It cannot be stated that the
proportion of the population with micronutrient intakes
above the UL has too high intakes; however, they are
potentially at risk as having too high intakes and, as a
consequence, potentially at risk of adverse health effects.
There is an established paradigm for determining safe
intakes of foreign compounds, such as food additives,
based on the dose-response relationship for adverse
health effects in animals or humans (19). A similar
paradigm can be applied for micronutrients (20). How-
ever it should be taken into account that, different from
foreign compounds, micronutrients are subject to homeo-
static control whereby the body content is regulated over
a range of intakes. Homeostasis reduces not only the risk
of depletion of body pools when intakes are low, but also
reduces the risk of excessive accumulation when intakes
are high. Furthermore, unlike foreign compounds,
nutrients are also required at a certain dose. For most
types of toxicity from either foreign compounds or
nutrients, there is believed to be a threshold dose (or
intake) at and below which adverse health effects do
not occur. Uncertainty factors are used to allow, for
instance, human variability and species differences when
necessary (19).
The risk-assessment paradigm consists of four steps:
hazard identification, hazard characterisation, exposure
assessment, and risk characterisation (18). The first two
steps of the risk assessment paradigm are required for
determining the UL. In the last two steps the intake levels
are evaluated. The initial step of hazard identification
includes the collection and evaluation of all micronutrient
information relating to the capacity of the micronutrient
to potentially cause adverse health effects. The next step,
hazard characterisation, a dose-response assessment (or
otherwise a semi-quantitative evaluation) is performed
taking into account the scientific uncertainties. The UL
can be derived from this dose-response curve. The
traditional approach in setting the UL is to first
find the no-observed adverse effect level (NOAEL),
which is the highest intake of a micronutrient at which
the adverse health effect(s) has not been observed (Fig.
2). If there are no data to demonstrate a NOAEL, as an
alternative, a lowest-observed adverse effect level LOAEL
may be used. This is the lowest intake of a micronutrient
at which the adverse health effect has been observed.
Where different adverse health effects occur, for each
health effect, a NOAEL (or LOAEL) can be derived and
these may differ. The health effect with the lowest
NOAEL is called the critical effect and is used for the
derivation of the UL. The NOAEL (LOAEL) is sur-
rounded by several scientific uncertainties due to, for
instance, extrapolations from animals to humans. To
correct for these uncertainties, an uncertainty factor is
applied to the NOAEL in order to derive the UL. The
higher the uncertainty, the higher the uncertainty factor
and, consequently, the lower the UL. As micronutrients
are essential dietary constituents, the population refer-
ence intakes (nutritional needs) should be kept in mind
when setting the UL. Due to a high uncertainty factor,
caution must be taken not to estimate the UL below the
PRI, which also could result in undesired health effects.
Similar to population reference intakes, ULs are
derived for all groups of the general healthy population,
including sensitive individuals, throughout the life stage.
Upper intake levels have been derived for a number of
micronutrients (1, 9, 18, 2125) (Table 1). Experience has
shown that it is not always possible to establish a UL for
a micronutrient for different reasons: (a) evidence of the
absence of any adverse health effects even at high intakes
e.g. vitamin B1 (18), (b) absence of evidence of any
adverse effect (which does not necessarily mean that there
is no potential for adverse effects resulting from high
intake) e.g. biotin (18), and (c) evidence of adverse effects
low or high intake vitamins and minerals
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but insufficient data on which to base a dose-response
assessment e.g. b-carotene (24) and manganese (2).
Benefit-risk assessment of vitamins and minerals
Many micronutrients have adverse health effects at both
too low and too high intakes. Besides classical deficiency
symptoms, there is promising evidence that micronutri-
ent intakes are also associated with reduced risks on
other health effects (e.g. chronic diseases). The levels
associated with this risk reduction may be higher than
the levels required to prevent classic deficiency symp-
toms and may also be different for subpopulations. On
the other hand, the UL is set in a way that even the most
sensitive subjects are protected. Seriousness of the
adverse health effect, incidence at a specific dose, and
in subpopulations are not taken into account. Balancing
all these benefits and risks is an important issue for
policy makers and the food industry. Especially, as there
is an ongoing increase of availability of over-the-counter
dietary supplements and (voluntary) fortified foods. This
may result in increased differences in micronutrient
intakes within populations.
For a long time the process of risk assessment and
benefit assessment of micronutrients have been separate
processes (12, 26). It is increasingly recognised that an
integrated benefit-risk assessment approach is required
(2732). A benefit-risk comparison weighs potential
health advantages versus health disadvantages, thereby
allowing for a better-informed choice from a public
health perspective (29, 33). Benefit-risk assessment begins
with a question relating to a whole diet, a food or a food
component (e.g. micronutrient), and the positive/negative
health effects associated with it. Hoekstra et al. (29, 30)
have proposed an integrated benefit-risk model that
allows the assessment of both beneficial and hazardous
effects of a micronutrient with balancing potential health
risks and health benefits using the common health
measure disability adjusted life years (DALYs). The
model was mirrored on the established paradigm for
risk analysis (28) and consisted of (1) hazard and benefit
identification, (2) hazard and benefit characterisation
through dose-response functions, (3) exposure assess-
ment, and (4) benefit-risk integration using a common
health measure (DALYs). The case study showed how the
benefit-risk approach may assist in decisions on any
voluntary or obligatory food fortification programmes. It
also illustrated general problems regarding data de-
mands, assumptions, and uncertainties (29, 30). The use
of a benefit-risk model as demonstrated by Hoekstra
et al. (30) provides an insightful opportunity for policy
makers to assess the potential health impact of, for
instance, food fortification. However, a similar approach
can be applied for other nutritional questions balancing
health benefits and risks.
It has been noted that a benefit-risk analysis may not
always be necessary or even possible, given the amount/
lack of data available on a given area. The EFSA has
suggested that a benefit-risk analysis should only be
performed when a substantial public health impact is
expected (28, 33). Fransen et al. (33), Hoekstra et al. (29,
33), and EFSA (28) have proposed a tiered approach for
the benefit-risk assessment of foods. These tiered
approaches use the same four benefit-risk steps as the
model of Hoekstra et al. (30). The key aspect of the
tiered approach is the use of several ‘stop’ moments,
depending on whether the information gathered is
sufficient to address the initial benefit-risk question.
The use of such an approach allows a case-by-case
assessment and enables the policy maker to decide when
to stop or to continue with a benefit-risk assessment (28,
29, 33).
Risk of Inadequacy Risk of adverse effect
Safe range of intake
Uncertainty factors
UL NOAELRLV LOAEL
Intake food and water
Intake
R
is
k
Fig. 2. Theoretical description of adverse health effects of a nutrient as a result of too low or too high intakes. Abbreviations:
NOAEL  no observed adverse effect level; LOAEL  lowest observed adverse effect level; UL  tolerable upper intake level;
RLV  reference labelling values (RDA  recommended daily allowance for labelling purposes).
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Safe addition of vitamins and minerals to
foods and supplements
The proliferation in the production and use of (volun-
tary) fortified foods and dietary supplements has required
regulation of these products to ensure the safety of the
whole population from unacceptably high intakes. Reg-
ulation is needed, for example, to define which chemical
form of a nutrient is allowed in these products and the
amount of a nutrient that can be added. Within the EU
there is existing legislation for the addition of micronu-
trients to foods (Regulation 1995/2006) (34) and food
supplements (Directive 2002/46) (35). However the al-
lowed levels of nutrients are currently under discussion
and not defined.
The first step in setting maximum nutrient levels for
food fortification and supplementation is to define what
‘free space’ is available for each nutrient next to dietary
intake from a regular diet (excluding voluntary fortifica-
tion and dietary supplements). This ‘free space’ is the
maximum amount of a nutrient that is available for total
intake from food fortification and dietary supplements.
The logical next step is how to divide this ‘free space’ over
foods to be fortified and dietary supplements. This can be
in any ratio, from 100% for food fortification to 100% for
dietary supplements (Fig. 3). This decision is one of risk
management or policy, unlike science. Whatever ratio
is chosen, it has an effect on the final maximum levels
allowed in food fortification and dietary supplements
(36).
Several models have been developed to estimate the
maximum level of a nutrient for food fortification level
and in dietary supplements (3641). In all these models
Table 1. Health effects and tolerable upper intake levels of vitamins, minerals and trace elements
Tolerable upper intake levele
Vitamin Inadequacy effects Excess effects EFSAb IOMc UK-EVMd
Vitamin A (retinol) Blindness, night blindness,
impaired immune status,
impaired resistance to
disease
Liver damage, foetal
abnormalities, increased risk
of hip fracture, increased
cranial pressure (baby’s)a
3000 mg (excluding
postmenopausal women)
3000 mg 1500 mg (GL)
Vitamin D (calciferol) Rickets, osteomalacia Hypercalcaemia, weakness 50 mg 50 mg 25 mg (GL)
Vitamin E (tocopherol) Neurological problems Decreased blood coagulation
in persons on anticoagulation
drugs
300 mg 1000 mg 800 mg (IU, UL)
Pyridoxine (vitamin B6) Seborrheic dermatitis-like
eruption, anaemia, reduced
resistance to disease,
neuropathy
Neurotoxicity 25 mg 100 mg 10 mg (UL)
Zinc Among others: growth
retardation, diarrhoea,
increased susceptibility to
infections
Impaired copper absorption 25 mg 40 mg 25 mg (UL)
Selenium Keshan disease (and possibly
also Kashin-Beck disease)
Selenosis (gastrointestinal
disorders, hair loss, sloughing
of nails, fatigue, neurological
damage)
300 mg 400 mg 450 mg (UL)
Iodine Iodine deficiency disorders
(among others: goitre,
suboptimal brain functioning,
impaired learning ability,
growth retardation, cretinism)
Thyroid hyperactivity 600 mg 1100 mg 500 mg (GL)
aSome ‘provitamin A carotenoids’ have vitamin A activity: e.g. beta-carotene, alpha-carotene, and beta-cryptoxanthin. Therefore the food content for
vitamin A is expressed in retinol-activity equivalents. Whereas provitamin A carotenoids do have vitamin A activity, they do not have vitamin A toxicity,
albeit that they can have toxic potential by themselves (e.g. beta-carotene for smokers).
bEvaluation by the EU Scientific Committee on Food/European Food Safety Authority (18).
cEvaluation by the USA Institute of Medicine  Food and Nutrition Board (9).
dEvaluation by the UK Expert Group on Vitamins and Minerals (21). ULupper level, GLguidance level (when the database is insufficient to establish
a UL or when no adverse effect has been identified).
low or high intake vitamins and minerals
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the UL is used as an upper limit for the total intake to
make sure that the high intake will not harm public
health. From the (age-specific) population nutrient intake
distribution, a specific percentile of intake is chosen to
represent the intake from a regular diet (i.e. without
voluntary fortification and dietary supplements). Often
the 95th percentile is used, as subjects with a high intake
should be protected from excessive intakes due to
additional consumption of fortified foods and/or dietary
supplements. However, in theory any other percentile can
be considered. The ‘free space’ is then the difference
between the UL and the regular intake at the 95th
percentile. As both UL and intake differ between age-
gender groups, this should be calculated for each group
separately. Furthermore, as a decision is made about the
distribution ratio of the ‘free space’ for food fortification
and/or dietary supplements the maximum amounts can
be calculated. For dietary supplements, this is a straight
forward method as the maximum amount is the max-
imum level that may be available in one daily dose. For
food fortification, it is less straight forward as the
maximum amount available for food fortification should
be divided over many foods. In the different models this is
solved by estimating a maximum fortification level per
food portion or per 100 kcal of a food (3740). In
addition, a maximum proportion of the energy intake
that may and will be fortified or a maximum number of
food portions to be fortified can be estimated.
Conclusion
This paper gives an overview of the state of the art on
issues related to too low and too high intake of
micronutrients. It is important to have insight into the
population micronutrient intake as both too low and too
high intakes may be associated with adverse health effects
and should be prevented or balanced. Insight into
population intake distributions may assist policy makers
on how to achieve adequate intakes in the whole
population (not too low or too high). Helpful tools are
PRIs and ULs that are set by different (inter)national
expert committees; however, large differences exist.
Harmonisation of methodologies to set threshold levels
(PRI, UL) is needed and is an ongoing process (5, 6, 8).
More and more knowledge on associations between
micronutrient intake or status and health effects is
gathered (42). This may result in conflicting advice at a
population level as what is beneficial for one specific
subpopulation may be harmful for another subpopula-
tion. In a benefit-risk assessment the effect on subpopu-
lations, the seriousness, and incidence of a health effect
will be taken into account to balance the beneficial and
harmful health effects. Such a benefit-risk assessment will
give insight into the different health effects in more detail
and will result in better informed decision making.
Nevertheless, a full benefit-risk assessment is not always
needed.
In the EU, setting maximum levels for addition of
vitamins and minerals to foods and dietary supplements
is currently under discussion. Although several models
have been proposed, it remains difficult to set one
maximum value for the whole of Europe. The setting of
maximum levels is a task where scientists need to advise
policy makers. Some of the decisions that have to
be made, for example, which part of the population are
protected from too high intakes and how to divide the
‘free space’ over fortification and/or dietary supplements,
need to be a priority by risk managers. Scientists should
assist this process by showing the impact of a specific
choice.
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